TVRD

Tvardi Therapeutics, Inc. Common Stock
TVRD

Overview Fund Activity

135 hedge funds and large institutions have $438M invested in Tvardi Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 35 increasing their positions, 43 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
2.93%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
22
Increased
35
Reduced
43
Closed
21
Calls
$16.3M
Puts
$15.6M
Net Calls
+$717K
Net Calls Change
+$2.06M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$5.25M
2
OM
Opaleye Management
Massachusetts
+$3.92M
3
First Manhattan
First Manhattan
New York
+$2.84M
4
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$2.39M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.38M

Top Sellers

1
EMG
ETF Managers Group
New Jersey
-$7.62M
2
State Street
State Street
Massachusetts
-$7.01M
3
Deutsche Bank
Deutsche Bank
Germany
-$5.69M
4
Millennium Management
Millennium Management
New York
-$5.67M
5
Renaissance Technologies
Renaissance Technologies
New York
-$5.37M
Name Holding Trade Value Shares
Change 		Shares
Change %
NIT
151
NumerixS Investment Technologies
British Columbia, Canada
– -$121K -264 Closed
AWM
152
Aevitas Wealth Management
Massachusetts
– -$26K -56 Closed
NFG
153
Next Financial Group
Texas
– -$14K -31 Closed
PRC
154
Pearl River Capital
Michigan
– -$10K -22 Closed
PCM
155
Prelude Capital Management
New York
– -$6K -13 Closed
GWMIA
156
Global Wealth Management Investment Advisory
Florida
– -$3K -6 Closed
3 4 5 6
7